Condition: Lower Cross Syndrome · Sponsor: Riphah International University
The goal of this randomized clinical trial is to learn if the given interventions that is jandas approach versus Proprioceptive Neuromuscular Facilitation technique can treat pain, disability, range of motion, endurance and quality of life in patients with Lower cross syndrome on both genders and age group of 25-40 years. The main questions it aims to answer are: Does jandas approach versus Proprioceptive neuromuscular facilitation technique improves pain, disability, range of motion, endurance and quality of life in patients with lower cross syndrome? There is a comparison between two groups: Researchers will compare the jandas approach and proprioceptive neuromuscular facilitation technique to see if there is effects on pain, disability, range of motion, endurance and quality of life in patients with lower cross syndrome. Participants in group A will be given * Heating pad for 10 minutes * Core stability exercises for 20 minutes with 10 seconds of rest intervals * Proprioceptive Neuromuscular Facilitation technique was used for stretching of erector spinae, quadratus lumborum, rectus femoris and iliopsoas and rhythmic stabilization technique for strengthening. Stretching was performed using contract-relax technique in supine, prone and side lying positions. The Contract-Relax method included the target muscle to be lengthened and held in lengthened position while the patient contracted the Target-Muscle to its maximum position isometrically 3 to 6 seconds. * Rhythmic st…
This description comes directly from the study's public registry record.
Imran Amjad, Phd · 03324390125 · imran.amjad@riphah.edu.pk
Always discuss trial participation with your own doctor first.
| Riphah Rehab Training and Research Center | Lahore, Punjab Province, Pakistan | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06737900